Potent inhibition of genital herpesvirus infection in goats by cidofovir

Antiviral Therapy

Volumn 12, Issue 6, 2007, Pages 977-979

  Tempesta, Maria ^a   Camero, Michele ^a   Bellacicco, Anna Lucia ^a   Tarsitano, Elvira ^a   Crescenzo, Giuseppe ^a   Thiry, Julien ^b   Martella, Vito ^a   Decaro, Nicola ^a   Elia, Gabriella ^a   Neyts, Johan ^c   Thiry, Etienne ^b   Buonavoglia, Canio ^a  

^a UNIVERSITY OF BARI   (Italy)

^b UNIVERSITY OF LIÈGE   (Belgium)

^c REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CIDOFOVIR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; EDEMA; FEMALE; GENITAL HERPES; GOAT; HERPES SIMPLEX VIRUS 1; HYPEREMIA; HYPERTHERMIA; NONHUMAN; PRIORITY JOURNAL; VIRUS SHEDDING;

ANIMALS; ANTIVIRAL AGENTS; CYTOSINE; GOATS; HERPES GENITALIS; HERPESVIRIDAE INFECTIONS; PHOSPHONIC ACIDS; VARICELLOVIRUS;

EID: 34848909640     PISSN: 13596535     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Corey L, Handsfield HH. GH and public health. J Am Med Assoc 2000; 283:791-794.
2. Malkin JE. Epidemiology of genital herpes simplex virus infection in developed countries. Herpes 2004; 11 Suppl 1:2A-23A.
3. Xu F, Stenberg MR, Kottiri BJ, et al. Trends in herpes simplex virus type 1 and type 2 seroprevalence in the United States. J Am Med Assoc 2006; 296:964-973
4. Paz-Bailey G, Ramaswamy M, Hawkes SJ, Geretti AM. Herpes simplex virus type 2: epidemiology and management options in developing countries Sex Transm Inf 2007; 83:16-22.
5. Deback C, Huraux JM. Herpes simplex virus vaccines: perspectives. Revue Méd Inter 2007; 28:16-21.
6. Lebrun-Vignes B, Bouzamondo A, Dupuy A, Guillaume JC, Lechat P, Chosidow O. A meta-analysis to assess the efficacy of oral antiviral treatment to prevent genital herpes outbreaks. J Am Acad Dermatol 2007; 57:238-246.
7. De Clercq E. Antiviral drugs in current clinical use. J Clin Virol 2004; 30:115-133.
8. De Clercq E, Holy A. Acyclic nucleoside phosphonates: a key class of antiviral drugs. Nature Rev Drug Disc 2005; 4:928-940.
9. Tempesta M, Pratelli A, Normanno G, et al. Experimental intravaginal infection of goats with caprine herpesvirus 1. J Vet Med B 2000; 47:145-151.
10. Tempesta M, Buonavoglia D, Sagazio P, Pratelli A, Buonavoglia C. Natural reactivation of caprine herpesvirus 1 in latently infected goats. Vet Rec 1998; 143:200.
11. Tempesta M, Pratelli A, Greco G, Martella V, Buonavoglia C. Detection of caprine herpesvirus 1 (CpHV-1) in the sacral ganglia of latently infected goats by polymerase chain reaction. J Clin Microbiol 1999; 37:1598-1599.
12. Tempesta M, Camero M, Bellacicco AL, et al. Cidofovir is effective against caprine herpesvirus 1 infection in goats. Antivir Res 2007; 74:138-141.
13. Buonavoglia C, Tempesta M, Cavalli A, et al. Reactivation of caprine herpesvirus 1 in latently infected goats. Comp Immunol Microbiol Infect Dis 1996; 19:275-281.
14. Stragier I, Snoeck R, De Clercq E, Van Den Oord JJ, Van Ranst M, De Greef H. Local treatment of HPV-induced skin lesions by cidofovir. J Med Virol 2002; 67:241-245.
15. Tempesta M, Greco G, Pratelli A, et al. Reactivation of caprine herpesvirus 1 in experimentally infected goats. Vet Rec 2002; 150:116-117.